GreenLight Biosciences or the RNA at every level
After genetic sequences and DNA, here comes RNA, the new flagship molecule in biotechnology that is supposed to solve agricultural and health problems. Companies in this field are flourishing. Among them is GreenLight Biosciences, a company that was on the verge of bankruptcy when it was bought by the investment fund Fall Line Capital.
GMOs: the Commission ignores its experts to reassure industry
GMO mosquitoes: Oxitec comes back to Panama
Journal
Patents on life: medicine and “disruptive technologies”
Oxitec: after mosquitoes, GMO ticks
